Revenue
2018
2019
2020
2021
2022
2023
2024
2025
vTv Therapeutics Inc. (VTVT)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1.0M | $0 | $2.0M | $4.0M | $6.4M | $2.8M | $12.4M | $291,000 | $634,000 | $519,000 | $1.5M | $976,000 |
| Research & development | $17.9M | $11.5M | $13.6M | $12.4M | $13.3M | $11.0M | $15.1M | $23.0M | $39.6M | $45.0M | $27.2M | $17.4M | $22.3M |
| Operating expenses | $32.8M | $25.2M | $25.5M | $24.6M | $25.7M | $18.3M | $23.7M | $32.3M | $51.0M | $55.7M | $38.7M | $30.4M | $36.8M |
| Operating income | −$32.8M | −$24.2M | −$25.5M | −$22.5M | −$21.7M | −$11.9M | −$20.9M | −$19.8M | −$50.7M | −$55.0M | −$38.1M | −$28.9M | −$35.8M |
| Net income | −$27.0M | −$18.5M | −$20.3M | −$19.2M | −$13.0M | −$8.5M | −$13.0M | −$7.9M | −$16.1M | −$16.4M | −$27.5M | −$36.1M | −$48.2M |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 18, 2024Form 4 · 10b5-1 | SEKHRI PAUL JPres, CEO and Exec Chairperson | BuyClass A Common Stock | 1.8K | $16.96 | $31.3K | 5.0K |
| Nov 15, 2024Form 4 · 10b5-1 | SEKHRI PAUL JPres, CEO and Exec Chairperson | BuyClass A Common Stock | 1.8K | $16.88 | $30.0K | 3.2K |
| Nov 15, 2024Form 4 · 10b5-1 | SEKHRI PAUL JPres, CEO and Exec Chairperson | BuyClass A Common Stock | 1.4K | $16.35 | $22.5K | 1.4K |